Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
March-2019 Volume 41 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2019 Volume 41 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Biological characterisation and application of human MTH1 and monoclonal antibody preparation

  • Authors:
    • Chuyuan Chen
    • Xiaoping Li
    • Mengyue Gu
    • Rongrong Di
    • Nannan Kang
    • Lei Wang
    • Yisheng Lai
    • Yu Liu
    • Xuemei Ji
  • View Affiliations / Copyright

    Affiliations: State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China, Hainan Institute of Drug Research, Haikou, Hainan 570311, P.R. China, State Key Laboratory of Natural Medicines, School of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China
  • Pages: 1851-1862
    |
    Published online on: December 19, 2018
       https://doi.org/10.3892/or.2018.6942
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Human MutT homolog 1 (MTH1) hydrolyses oxidised nucleotide triphosphates, thereby preventing them from being incorporated into DNA; MTH1 has been found to be elevated in many types of cancers, including lung, stomach cancer, melanoma and breast cancer. Thus, tumour‑targeted hMTH1 may be valuable for developing novel anticancer therapies. In the present study, we prepared human MTH1 protein and its monoclonal antibody (mAb). The hMTH1 gene was cloned into the prokaryotic expression vector pET28a and optimally expressed in the E. coli Transetta (DE3) strain. Using an Ni‑NTA column and a G‑50 gel filtration column, 20.1 mg of active hMTH1 was obtained from 1,000 ml of bacterial culture, and the purity was over 98%, as detected by high‑performance liquid chromatography (HPLC). The half maximal inhibitory concentration (IC50) of TH287 (hMTH1 inhibitor) was determined to be 3.53±0.47 nM using the recombinant hMTH1 protein (rhMTH1). The enzyme activity assay showed the Michaelis constant (Km) and the catalytic constant (kcat) of the protein were 106.13±48.83 µM and 3.64±0.58 sec‑1, respectively. The anti‑hMTH1 mAb was obtained via the hybridoma technique and validated by western blot analysis. In addition, an immunofluorescence assay (IFA) and ELISA determined that the mAb could efficiently bind to natural hMTH1 expressed on the human breast cancer cell line MCF‑7. Taken together, the results showed the rhMTH1 is an active protein and has practical applications for inhibitor selection, and our prepared hMTH1 mAb will provide a valuable tool for the further characterisation of hMTH1 and antitumour medicinal development in future.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Luo M, He H, Kelley MR and Georgiadis MM: Redox regulation of DNA repair: Implications for human health and cancer therapeutic development. Antioxid Redox Signal. 12:1247–1269. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Rai P: Human Mut T Homolog 1 (MTH1): A roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS. Small GTPases. 3:120–125. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Puigvert JC, Sanjiv K and Helleday T: Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies. FEBS J. 283:232–245. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Nakabeppu Y: Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells. Int J Mol Sci. 15:12543–12557. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Gao T, Gu S, Liu F, Li L, Wang Z, Yang J and Li G: Investigation of MTH1 activity via mismatch-based DNA chain elongation. Anal Chim Acta. 905:66–71. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Nakabeppu Y, Ohta E and Abolhassani N: MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe. Free Radic Biol Med. 107:151–158. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Fujikawa K, Kamiya H, Yakushiji H, Nakabeppu Y and Kasai H: Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP. Nucleic Acids Res. 29:449–454. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Bialkowski K, Szpila A and Kasprzak KS: Up-regulation of 8-oxo-dGTPase activity of MTH1 protein in the brain, testes and kidneys of mice exposed to 137Cs γ radiation. Radiat Res. 172:187–197. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Waz S, Nakamura T, Hirata K, Koga-Ogawa Y, Chirifu M, Arimori T, Tamada T, Ikemizu S, Nakabeppu Y and Yamagata Y: Structural and kinetic studies of the human nudix hydrolase MTH1 reveal the mechanism for its broad substrate specificity. J Biol Chem. 292:2785–2794. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Maki H and Sekiguchi M: MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature. 355:273–275. 1992. View Article : Google Scholar : PubMed/NCBI

12 

Tsuzuki T, Egashira A and Kura S: Analysis of MTH1 gene function in mice with targeted mutagenesis. Mutat Res. 477:71–78. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T, Einarsdottir BO, et al: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 508:215–221. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Wang JY, Liu GZ, Wilmott JS, La T, Feng YC, Yari H, Yan XG, Thorne RF, Scolyer RA, Zhang XD and Jin L: Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress. Cancer Res. 77:6226–6239. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Kennedy CH, Cueto R, Belinsky SA, Lechner JF and Pryor WA: Overexpression of hMTH1 mRNA: A molecular marker of oxidative stress in lung cancer cells. FEBS Lett. 429:17–20. 1998. View Article : Google Scholar : PubMed/NCBI

16 

Borrego S, Vazquez A, Dasí F, Cerdá C, Iradi A, Tormos C, Sánchez JM, Bagán L, Boix J, Zaragoza C, et al: Oxidative stress and DNA damage in human gastric carcinoma: 8-Oxo-7′8-dihydro-2′-deoxyguanosine (8-oxo-dG) as a possible tumor marker. Int J Mol Sci. 14:3467–3486. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Huber KV, Salah E, Radic B, Gridling M, Elkins JM, Stukalov A, Jemth AS, Göktürk C, Sanjiv K, Strömberg K, et al: Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature. 508:222–227. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Svensson LM, Jemth AS, Desroses M, Loseva O, Helleday T, Högbom M and Stenmark P: Crystal structure of human MTH1 and the 8-oxo-dGMP product complex. FEBS Lett. 585:2617–2621. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Koga Y, Inazato M, Nakamura T, Hashikawa C, Chirifu M, Michi A, Yamashita T, Toma S, Kuniyasu A, Ikemizu S, et al: Crystallization and preliminary X-ray analysis of human MTH1 with a homogeneous N-terminus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 69:45–48. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Carter M, Jemth AS, Hagenkort A, Page BD, Gustafsson R, Griese JJ, Gad H, Valerie NC, Desroses M, Boström J, et al: Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2. Nat Commun. 6:78712015. View Article : Google Scholar : PubMed/NCBI

21 

Ellermann M, Eheim A, Rahm F, Viklund J, Guenther J, Andersson M, Ericsson U, Forsblom R, Ginman T, Lindström J, et al: Novel class of potent and cellularly active inhibitors devalidates MTH1 as broad-Spectrum cancer target. ACS Chem Biol. 12:1986–1992. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Köhler G and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:495–497. 1975. View Article : Google Scholar : PubMed/NCBI

23 

Fan X, He C, Jing W, Zhou X, Chen R, Cao L, Zhu M, Jia R, Wang H and Guo Y: Intracellular osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis. Cancer Res. 75:86–97. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Cornelissen B, Hu M, McLarty K, Costantini D and Reilly RM: Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells. Nucl Med Biol. 34:37–46. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Lee Y, Ishii T, Kim HJ, Nishiyama N, Hayakawa Y, Itaka K and Kataoka K: Efficient delivery of bioactive antibodies into the cytoplasm of living cells by charge-conversional polyion complex micelles. Angew Chem Int Ed Engl. 49:2552–2555. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Yamada Y, Perez SM, Tabata M, Abe J, Yasuzaki Y and Harashima H: Efficient and high-speed transduction of an antibody into living cells using a multifunctional nanocarrier system to control intracellular trafficking. J Pharm Sci. 104:2845–2854. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Shin SM, Choi DK, Jung K, Bae J, Kim JS, Park SW, Song KH and Kim YS: Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration. Nat Commun. 8:150902017. View Article : Google Scholar : PubMed/NCBI

28 

Baykov AA, Evtushenko OA and Avaeva SM: A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem. 171:266–270. 1988. View Article : Google Scholar : PubMed/NCBI

29 

Malik A, Alsenaidy AM, Elrobh M, Khan W, Alanazi MS and Bazzi MD: Optimization of expression and purification of HSPA6 protein from Camelus dromedarius in E. coli. Saudi J Biol Sci. 23:410–419. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Coskun E, Jaruga P, Jemth AS, Loseva O, Scanlan LD, Tona A, Lowenthal MS, Helleday T and Dizdaroglu M: Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry. DNA Repair. 33:101–110. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Ji D, Beharry AA, Ford JM and Kool ET: A Chimeric ATP-Linked nucleotide enables luminescence signaling of damage surveillance by MTH1, a cancer target. J Am Chem Soc. 138:9005–9008. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Nakabeppu Y: Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Prog Nucleic Acid Res Mol Biol. 68:75–94. 2001. View Article : Google Scholar : PubMed/NCBI

33 

Fujikawa K, Kamiya H, Yakushiji H, Fujii Y, Nakabeppu Y and Kasai H: The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein. J Biol Chem. 274:18201–18205. 1999. View Article : Google Scholar : PubMed/NCBI

34 

Yakushiji H, Maraboeuf F, Takahashi M, Deng ZS, Kawabata S, Nakabeppu Y and Sekiguchi M: Biochemical and physicochemical characterization of normal and variant forms of human MTH1 protein with antimutagenic activity. Mutat Res. 384:181–194. 1997. View Article : Google Scholar : PubMed/NCBI

35 

Ling S, Xiao S, Xie C, Wang R, Zeng L, Wang K, Zhang D, Li X and Wang S: Preparation of monoclonal antibody for brevetoxin 1 and development of Ic-ELISA and colloidal gold strip to detect brevetoxin 1. Toxins. 10:E752018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen C, Li X, Gu M, Di R, Kang N, Wang L, Lai Y, Liu Y and Ji X: Biological characterisation and application of human MTH1 and monoclonal antibody preparation. Oncol Rep 41: 1851-1862, 2019.
APA
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L. ... Ji, X. (2019). Biological characterisation and application of human MTH1 and monoclonal antibody preparation. Oncology Reports, 41, 1851-1862. https://doi.org/10.3892/or.2018.6942
MLA
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L., Lai, Y., Liu, Y., Ji, X."Biological characterisation and application of human MTH1 and monoclonal antibody preparation". Oncology Reports 41.3 (2019): 1851-1862.
Chicago
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L., Lai, Y., Liu, Y., Ji, X."Biological characterisation and application of human MTH1 and monoclonal antibody preparation". Oncology Reports 41, no. 3 (2019): 1851-1862. https://doi.org/10.3892/or.2018.6942
Copy and paste a formatted citation
x
Spandidos Publications style
Chen C, Li X, Gu M, Di R, Kang N, Wang L, Lai Y, Liu Y and Ji X: Biological characterisation and application of human MTH1 and monoclonal antibody preparation. Oncol Rep 41: 1851-1862, 2019.
APA
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L. ... Ji, X. (2019). Biological characterisation and application of human MTH1 and monoclonal antibody preparation. Oncology Reports, 41, 1851-1862. https://doi.org/10.3892/or.2018.6942
MLA
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L., Lai, Y., Liu, Y., Ji, X."Biological characterisation and application of human MTH1 and monoclonal antibody preparation". Oncology Reports 41.3 (2019): 1851-1862.
Chicago
Chen, C., Li, X., Gu, M., Di, R., Kang, N., Wang, L., Lai, Y., Liu, Y., Ji, X."Biological characterisation and application of human MTH1 and monoclonal antibody preparation". Oncology Reports 41, no. 3 (2019): 1851-1862. https://doi.org/10.3892/or.2018.6942
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team